Zacks Investment Research downgraded shares of HealthSouth Corporation (NYSE:HLS) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning.
According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. “
HLS has been the topic of a number of other reports. Stephens initiated coverage on shares of HealthSouth Corporation in a research note on Thursday, August 31st. They issued an overweight rating and a $53.00 price target on the stock. Royal Bank Of Canada reissued a buy rating and issued a $55.00 price target on shares of HealthSouth Corporation in a research note on Wednesday, September 6th. KeyCorp reissued a hold rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. ValuEngine raised shares of HealthSouth Corporation from a hold rating to a buy rating in a research note on Friday, July 7th. Finally, BidaskClub downgraded shares of HealthSouth Corporation from a hold rating to a sell rating in a research note on Thursday, July 13th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $50.75.
Shares of HealthSouth Corporation (HLS) traded down 0.48% during mid-day trading on Tuesday, hitting $45.92. 274,972 shares of the stock traded hands. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71. The company has a market cap of $4.53 billion, a P/E ratio of 16.73 and a beta of 0.58. The firm has a 50 day moving average of $45.41 and a 200 day moving average of $45.62.
HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. HealthSouth Corporation had a net margin of 6.69% and a return on equity of 22.81%. The company had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. During the same period in the previous year, the firm earned $0.65 earnings per share. HealthSouth Corporation’s quarterly revenue was up 7.4% compared to the same quarter last year. Equities analysts anticipate that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date of this dividend is Friday, December 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is currently 36.36%.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the transaction, the chief executive officer now owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Advisor Group Inc. grew its holdings in HealthSouth Corporation by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after acquiring an additional 781 shares in the last quarter. Aviva PLC lifted its position in shares of HealthSouth Corporation by 67.5% during the 2nd quarter. Aviva PLC now owns 43,670 shares of the company’s stock worth $2,133,000 after buying an additional 17,600 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its position in shares of HealthSouth Corporation by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock worth $32,492,000 after buying an additional 34,035 shares during the last quarter. Mackay Shields LLC purchased a new stake in shares of HealthSouth Corporation during the 2nd quarter worth approximately $39,641,000. Finally, Prudential Financial Inc. lifted its position in shares of HealthSouth Corporation by 137.1% during the 2nd quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock worth $21,039,000 after buying an additional 251,372 shares during the last quarter. Institutional investors own 93.11% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
What are top analysts saying about HealthSouth Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corporation and related companies.